Compare · CTEK vs WGS
CTEK vs WGS
Side-by-side comparison of CynergisTek Inc. (CTEK) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CTEK and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- WGS is the larger of the two at $2.61B, about 148.6x CTEK ($17.5M).
- WGS has hit the wire 8 times in the past 4 weeks while CTEK has been quiet.
- WGS has more recent analyst coverage (8 ratings vs 0 for CTEK).
- Company
- CynergisTek Inc.
- GeneDx Holdings Corp.
- Price
- -
- -
- Market cap
- $17.5M
- $2.61B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- AMEX
- NASDAQ
- IPO
- 2017
- 2020
- News (4w)
- 0
- 8
- Recent ratings
- 0
- 8
CynergisTek Inc.
CynergisTek, Inc. provides cyber security, privacy, and compliance services in the United States. The company offers assessment and audit, technical testing, remediation, management, and validation services. It serves primarily in the healthcare industry, as well as education, financial services, government, internet and media, and manufacturing industries under the CynergisTek, Redspin, and Backbone Consulting brands. The company was formerly known as Auxilio, Inc. and changed its name to CynergisTek, Inc. in September 2017. CynergisTek, Inc. was incorporated in 1995 and is based in Austin, Texas.
Latest CTEK
- SEC Form EFFECT filed by CynergisTek Inc.
- SEC Form 15-12G filed by CynergisTek Inc.
- SEC Form S-8 POS filed by CynergisTek Inc.
- SEC Form S-8 POS filed by CynergisTek Inc.
- SEC Form S-8 POS filed by CynergisTek Inc.
- SEC Form S-8 POS filed by CynergisTek Inc.
- SEC Form POS AM filed by CynergisTek Inc.
- SEC Form 4: Mcmillan Michael Henry returned 663,333 shares to the company, closing all direct ownership in the company
- SEC Form 4: Mccashin Robert gave a grant of 35,000 shares and returned 99,500 shares to the company, closing all direct ownership in the company
- SEC Form 4: Meadows Theresa Zak was granted 25,000 shares and returned 89,500 shares to the company, closing all direct ownership in the company
Latest WGS
- GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
- SEC Form SCHEDULE 13G filed by GeneDx Holdings Corp.
- GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy
- Amendment: SEC Form SCHEDULE 13G/A filed by GeneDx Holdings Corp.
- GeneDx to Participate in Upcoming Investor Conferences
- SEC Form 10-Q filed by GeneDx Holdings Corp.
- GeneDx Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GeneDx Reports Second Quarter 2026 Financial Results
- SEC Form 25-NSE filed by GeneDx Holdings Corp.
- GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026